Results 121 to 130 of about 1,759 (167)

Plasma pTau181 and amyloid markers predict conversion to dementia in idiopathic REM sleep behaviour disorder. [PDF]

Brain
Delva A, Pelletier A, Somerville E, Montplaisir J, Gagnon JF, Kollmorgen G, Kam-Thong T, Kustermann T, Machado V, Gan-Or Z, Postuma RB.   +10 more
europepmc   +1 more source

Event-related potentials as neurophysiological predictors of high-risk isolated REM sleep behavior disorder patients. [PDF]

Sleep
Lanza G, Mogavero MP, Ferri R.
europepmc   +1 more source

A Narrative Review on Biochemical Markers and Emerging Treatments in Prodromal Synucleinopathies. [PDF]

Clin Pract
Rissardo JP, Caprara ALF.
europepmc   +1 more source

The Many Faces of REM Sleep Behavior Disorder. Providing Evidence for a New Lexicon. [PDF]

Eur J Neurol
Arnaldi D, Mattioli P, Orso B, Massa F, Pardini M, Morbelli S, Nobili F, Figorilli M, Casaglia E, Mulas M, Terzaghi M, Capriglia E, Malomo G, Solbiati M, Antelmi E, Pizza F, Biscarini F, Puligheddu M, Plazzi G.   +18 more
europepmc   +1 more source

Multimodal Autonomic Biomarkers Predict Phenoconversion in Pure Autonomic Failure

Shiwen Koay, Ekawat Vichayanrat, Fion Bremner, Fernanda Valério, Robin Mackenzie, Giacomo Chiaro, GK Ingle, Patricia McNamara, Lucy C. Watson, Jalesh N. Panicker, Michael P. Lunn, C. J. Mathias, Valeria Iodice   +12 more
openalex   +1 more source

Prevalence Estimates of Cytochrome P450 Phenoconversion in Youth Receiving Pharmacotherapy for Mental Health Conditions. [PDF]

Clin Pharmacol Ther
Gerlach S, Maruf AA, Shaheen SM, McCloud R, Heintz M, McAusland L, Arnold PD, Bousman CA.   +7 more
europepmc   +1 more source

Frequency and Implications of High-Risk Pharmacogenomic Phenotypes Identified in a Diverse Australian Pediatric Oncology Cohort. [PDF]

Clin Transl Sci
Moore C, Halman A, Stenta T, Khatri D, Williams E, Dyas R, Stolper J, Elliott DA, Conyers R.   +8 more
europepmc   +1 more source

Divergent Phenotypes, Actionable Genotypes, and Phenoconversion in a German Psychiatric Inpatient Population: Results from the FACT-PGx Study [PDF]

Andreas Eckert, Amelie Frantz, Maike Scherf‐Clavel, Heike Weber, Stefan Unterecker, Andreas Reif, Martina Hahn   +6 more
openalex   +1 more source

New developments in imaging in ALS. [PDF]

J Neurol
Kleinerova J, Querin G, Pradat PF, Siah WF, Bede P.   +4 more
europepmc   +1 more source

α-Synuclein Seed Amplification Assay Amplification Parameters and the Risk of Progression in Prodromal Parkinson Disease. [PDF]

Neurology
Coughlin DG, Shifflett B, Farris CM, Ma Y, Galasko D, Edland SD, Mollenhauer B, Brumm MC, Poston KL, Marek K, Siderowf AD, Soto C, Concha-Marambio L, as the Investigators of the Parkinson's Progression Marker Initiative.   +13 more
europepmc   +1 more source